About Us
Our Mission
Leadership
Board of Directors
Scientific Advisory Board
Our Technology
Therapeutic Platforms
SQZ Pipeline
SQZ APC PLATFORM
SQZ AAC PLATFORM
SQZ TAC PLATFORM
For Patients
Investors and Media
Work At SQZ
Join the Team
Contact Us
Media
Press Releases
All
2021
2020
2019
2018
2017
2016
2015
2014
September 10, 2021
SQZ Biotechnologies seeks to expand the universe of cell therapies
November 23, 2020
SQZ Biotech to Present at Evercore ISI Virtual HealthCONx Conference
November 12, 2020
SQZ Biotech to Present at November Virtual Investor Conferences
November 10, 2020
SQZ Biotech Presents Preclinical Data for SQZ APC and AAC Cellular Vaccine Platforms at SITC 2020, Including First-Time SQZ APC Combination Preclinical Data
October 30, 2020
SQZ Biotech Announces Pricing of Initial Public Offering
October 23, 2020
SQZ Biotech Strengthens Board of Directors and Appoints New Chief Business Officer
July 20, 2020
SQZ Biotech Appoints Paul Bolno, MD to Board of Directors and Kai Wucherpfennig, MD, PhD to Scientific Advisory Board
May 26, 2020
SQZ Biotech to Participate in June Investor Conferences
May 18, 2020
SQZ Biotech Closes $65 Million Series D Financing
May 11, 2020
SQZ Biotech to Present at UBS Virtual Global Healthcare Conference
January 30, 2020
SQZ Biotech Announces First Patient Dosed in Phase 1 Trial of SQZ-PBMC-HPV for HPV+ Tumors
November 12, 2019
SQZ Biotech to Present at Upcoming Investor Conferences in November & December
November 7, 2019
SQZ Biotech and AskBio Announce Research Collaboration to Create Immune Tolerization Products for AAV Gene Therapies
November 5, 2019
SQZ Biotech to Present First Time Data Demonstrating Potential of Company’s Second Novel Cell Therapy Approach in Oncology – Activating Antigen Carriers (AACs)
October 31, 2019
SQZ Biotech to Present New Data at the Society for Immunotherapy of Cancer’s 34th Annual Meeting
October 22, 2019
SQZ Biotech Announces Clearance of US IND Application for First Clinical Trial
September 17, 2019
SQZ Biotech Appoints Legal Life Sciences Expert, Lawrence Knopf, as General Counsel
August 7, 2019
SQZ Biotech Announces Appointment of Experienced Pharmaceutical Executive Teri Loxam as Chief Financial Officer
May 29, 2019
SQZ Biotech Strengthens Board of Directors with Appointment of Leading Cell Therapy Expert and Biotech Veteran
May 14, 2019
SQZ Biotech to Present at Investor Conferences in May & June
April 25, 2019
SQZ Biotech to Present at the American Society of Gene and Cell Therapy (ASGCT) 22nd Annual Meeting
March 28, 2019
SQZ Biotech to Present at the Jefferies Immuno-Oncology Cell Therapy Summit
March 5, 2019
SQZ Biotech to Present at Investor Conferences in March
February 28, 2019
SQZ Biotech to Present at the American Association for Cancer Research (AACR) 2019 Annual Meeting
January 3, 2019
SQZ Biotech Strengthens Leadership Team with Appointment of Chief Medical Officer
November 9, 2018
SQZ Biotech to Present at Investor Conferences in November
November 1, 2018
SQZ Biotech Announces PNAS Publication Demonstrating Significant Advantages of Its Cell Squeezing Technology for the Development of Cell-Based Therapeutics
October 15, 2018
SQZ Biotech Expands Cell Therapy Partnership with Roche to Develop Antigen Presenting Cells for Immune-Oncology
September 27, 2018
SQZ Biotech Announces Key Executive and Board of Directors Appointments
August 8, 2018
SQZ Completes Oversubscribed Series C
May 14, 2018
SQZ Biotech CEO to Participate in BIO International Panel and to Present at Investor Conferences in Second Quarter 2018
February 5, 2018
SQZ Biotech to Present at Investor Conferences in First Quarter 2018
December 5, 2017
SQZ Biotech Receives Investment from JDRF T1D Fund
June 14, 2017
SQZ Biotech Named a 2017 Technology Pioneer and Gives Corporate Update
December 1, 2016
SQZ Biotech Announces Additional $8 Million in Series B Funding Bringing Total Financing Round to $24 Million
September 30, 2016
SQZ Biotech Announces $16 Million Series B Funding Round Led by Nanodimension and Polaris Partners
December 7, 2015
SQZ Biotech Announces Partnership to Fight Cancer with Novel Cell Engineering Technology
June 23, 2015
SQZ Biotech Raises $5 Million Series A Round Led By Polaris Partners
November 18, 2014
SQZ Biotech’s CellSqueeze Featured as a Top 10 Innovation in Scientific American’s World Changing Ideas 2014
October 30, 2014
SQZ Biotech Launches SQZ Cell Therapy Platform and Is Awarded $100,000 Grand Prize from MassChallenge and over $200,000 from Boeing and the Center for the Advancement of Science in Space (CASIS)
